Global Non-Invasive Prenatal Screening (NIPS) Market Growth (Status and Outlook) 2026-2032
The global Non-Invasive Prenatal Screening (NIPS) market size is predicted to grow from US$ 3601 million in 2025 to US$ 5871 million in 2032; it is expected to grow at a CAGR of 7.4% from 2026 to 2032.
Non-Invasive Prenatal Screening (NIPS) is a prenatal testing method that analyzes genetic material from a pregnancy related blood sample to assess the risk of certain chromosomal or genetic conditions in the fetus without posing physical risk to the pregnancy. It is designed as a screening tool rather than a diagnostic test and is used to identify pregnancies that may benefit from further confirmatory testing and specialized clinical management.
The non invasive prenatal screening market has transitioned from a niche offering for high risk pregnancies into a mainstream component of prenatal care, driven by its strong clinical performance, low procedural risk, and growing acceptance among clinicians and expectant parents. Market dynamics are shaped by rapid technological standardization, intensifying competition, and gradual price compression, which together shift differentiation away from basic test availability toward service quality, turnaround time, reporting clarity, and integration with counseling and follow up pathways. While growth remains robust due to expanding geographic adoption and broader clinical indications, the market is increasingly influenced by reimbursement policy, ethical oversight, and evidence based guideline updates, positioning it as a mature but still structurally expanding segment within prenatal diagnostics.
LPI (LP Information)' newest research report, the ?Non-Invasive Prenatal Screening (NIPS) Industry Forecast? looks at past sales and reviews total world Non-Invasive Prenatal Screening (NIPS) sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-Invasive Prenatal Screening (NIPS) sales for 2026 through 2032. With Non-Invasive Prenatal Screening (NIPS) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Invasive Prenatal Screening (NIPS) industry.
This Insight Report provides a comprehensive analysis of the global Non-Invasive Prenatal Screening (NIPS) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-Invasive Prenatal Screening (NIPS) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Non-Invasive Prenatal Screening (NIPS) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Invasive Prenatal Screening (NIPS) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Invasive Prenatal Screening (NIPS).
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Invasive Prenatal Screening (NIPS) market by product type, application, key players and key regions and countries.
Segmentation by Type:
Non-Invasive Prenatal Screening (NIPS) is a prenatal testing method that analyzes genetic material from a pregnancy related blood sample to assess the risk of certain chromosomal or genetic conditions in the fetus without posing physical risk to the pregnancy. It is designed as a screening tool rather than a diagnostic test and is used to identify pregnancies that may benefit from further confirmatory testing and specialized clinical management.
The non invasive prenatal screening market has transitioned from a niche offering for high risk pregnancies into a mainstream component of prenatal care, driven by its strong clinical performance, low procedural risk, and growing acceptance among clinicians and expectant parents. Market dynamics are shaped by rapid technological standardization, intensifying competition, and gradual price compression, which together shift differentiation away from basic test availability toward service quality, turnaround time, reporting clarity, and integration with counseling and follow up pathways. While growth remains robust due to expanding geographic adoption and broader clinical indications, the market is increasingly influenced by reimbursement policy, ethical oversight, and evidence based guideline updates, positioning it as a mature but still structurally expanding segment within prenatal diagnostics.
LPI (LP Information)' newest research report, the ?Non-Invasive Prenatal Screening (NIPS) Industry Forecast? looks at past sales and reviews total world Non-Invasive Prenatal Screening (NIPS) sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-Invasive Prenatal Screening (NIPS) sales for 2026 through 2032. With Non-Invasive Prenatal Screening (NIPS) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Invasive Prenatal Screening (NIPS) industry.
This Insight Report provides a comprehensive analysis of the global Non-Invasive Prenatal Screening (NIPS) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-Invasive Prenatal Screening (NIPS) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Non-Invasive Prenatal Screening (NIPS) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Invasive Prenatal Screening (NIPS) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Invasive Prenatal Screening (NIPS).
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Invasive Prenatal Screening (NIPS) market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Screening in Uncomplicated Pregnancies
- Screening in High-Risk Pregnancies
- Others
- First-trimester Screening
- Second-trimester Screening
- Late-pregnancy Screening
- Public Health Program
- Consumer
- Others
- Public Hospitals
- Private Hospitals
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Revvity
- Quest Diagnostics
- MedGenome
- Mayo Clinic Laboratories
- SYNLAB
- Veritas Genetics
- GGA
- Cordlife
- BGI Genomics
- Berry Genomics
- Annaroad
- Genesky
- Weihansi Biomedical Technology
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032)
2.1.2 Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Non-Invasive Prenatal Screening (NIPS) by Country/Region (2021, 2025 & 2032)
2.2 Non-Invasive Prenatal Screening (NIPS) Segment by Type
2.2.1 Screening in Uncomplicated Pregnancies
2.2.2 Screening in High-Risk Pregnancies
2.2.3 Others
2.2.4 Non-Invasive Prenatal Screening (NIPS) Market Size by Type
2.2.4.1 Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2021-2026)
2.3 Non-Invasive Prenatal Screening (NIPS) Segment by Screening Timing
2.3.1 First-trimester Screening
2.3.2 Second-trimester Screening
2.3.3 Late-pregnancy Screening
2.3.4 Non-Invasive Prenatal Screening (NIPS) Market Size by Screening Timing
2.3.4.1 Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Screening Timing (2021 VS 2025 VS 2032)
2.3.4.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Screening Timing (2021-2026)
2.4 Non-Invasive Prenatal Screening (NIPS) Segment by Service Model
2.4.1 Public Health Program
2.4.2 Consumer
2.4.3 Others
2.4.4 Non-Invasive Prenatal Screening (NIPS) Market Size by Service Model
2.4.4.1 Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Service Model (2021 VS 2025 VS 2032)
2.4.4.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Service Model (2021-2026)
2.5 Non-Invasive Prenatal Screening (NIPS) Segment by Application
2.5.1 Public Hospitals
2.5.2 Private Hospitals
2.5.3 Non-Invasive Prenatal Screening (NIPS) Market Size by Application
2.5.3.1 Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.3.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2021-2026)
3 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET SIZE BY PLAYER
3.1 Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Player
3.1.1 Global Non-Invasive Prenatal Screening (NIPS) Revenue by Player (2021-2026)
3.1.2 Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Player (2021-2026)
3.2 Global Non-Invasive Prenatal Screening (NIPS) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-INVASIVE PRENATAL SCREENING (NIPS) BY REGION
4.1 Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2021-2026)
4.2 Global Non-Invasive Prenatal Screening (NIPS) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-Invasive Prenatal Screening (NIPS) Market Size Growth (2021-2026)
4.4 APAC Non-Invasive Prenatal Screening (NIPS) Market Size Growth (2021-2026)
4.5 Europe Non-Invasive Prenatal Screening (NIPS) Market Size Growth (2021-2026)
4.6 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026)
5.2 Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026)
5.3 Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2021-2026)
6.2 APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026)
6.3 APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026)
7.2 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026)
7.3 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) by Region (2021-2026)
8.2 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026)
8.3 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET FORECAST
10.1 Global Non-Invasive Prenatal Screening (NIPS) Forecast by Region (2027-2032)
10.1.1 Global Non-Invasive Prenatal Screening (NIPS) Forecast by Region (2027-2032)
10.1.2 Americas Non-Invasive Prenatal Screening (NIPS) Forecast
10.1.3 APAC Non-Invasive Prenatal Screening (NIPS) Forecast
10.1.4 Europe Non-Invasive Prenatal Screening (NIPS) Forecast
10.1.5 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Forecast
10.2 Americas Non-Invasive Prenatal Screening (NIPS) Forecast by Country (2027-2032)
10.2.1 United States Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.2.2 Canada Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.2.3 Mexico Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.2.4 Brazil Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.3 APAC Non-Invasive Prenatal Screening (NIPS) Forecast by Region (2027-2032)
10.3.1 China Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.3.2 Japan Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.3.3 Korea Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.3.4 Southeast Asia Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.3.5 India Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.3.6 Australia Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.4 Europe Non-Invasive Prenatal Screening (NIPS) Forecast by Country (2027-2032)
10.4.1 Germany Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.4.2 France Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.4.3 UK Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.4.4 Italy Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.4.5 Russia Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.5 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Forecast by Region (2027-2032)
10.5.1 Egypt Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.5.2 South Africa Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.5.3 Israel Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.5.4 Turkey Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.6 Global Non-Invasive Prenatal Screening (NIPS) Forecast by Type (2027-2032)
10.7 Global Non-Invasive Prenatal Screening (NIPS) Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Non-Invasive Prenatal Screening (NIPS) Forecast
11 KEY PLAYERS ANALYSIS
11.1 Revvity
11.1.1 Revvity Company Information
11.1.2 Revvity Non-Invasive Prenatal Screening (NIPS) Product Offered
11.1.3 Revvity Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Revvity Main Business Overview
11.1.5 Revvity Latest Developments
11.2 Quest Diagnostics
11.2.1 Quest Diagnostics Company Information
11.2.2 Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Product Offered
11.2.3 Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Quest Diagnostics Main Business Overview
11.2.5 Quest Diagnostics Latest Developments
11.3 MedGenome
11.3.1 MedGenome Company Information
11.3.2 MedGenome Non-Invasive Prenatal Screening (NIPS) Product Offered
11.3.3 MedGenome Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 MedGenome Main Business Overview
11.3.5 MedGenome Latest Developments
11.4 Mayo Clinic Laboratories
11.4.1 Mayo Clinic Laboratories Company Information
11.4.2 Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Product Offered
11.4.3 Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Mayo Clinic Laboratories Main Business Overview
11.4.5 Mayo Clinic Laboratories Latest Developments
11.5 SYNLAB
11.5.1 SYNLAB Company Information
11.5.2 SYNLAB Non-Invasive Prenatal Screening (NIPS) Product Offered
11.5.3 SYNLAB Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 SYNLAB Main Business Overview
11.5.5 SYNLAB Latest Developments
11.6 Veritas Genetics
11.6.1 Veritas Genetics Company Information
11.6.2 Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Product Offered
11.6.3 Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Veritas Genetics Main Business Overview
11.6.5 Veritas Genetics Latest Developments
11.7 GGA
11.7.1 GGA Company Information
11.7.2 GGA Non-Invasive Prenatal Screening (NIPS) Product Offered
11.7.3 GGA Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 GGA Main Business Overview
11.7.5 GGA Latest Developments
11.8 Cordlife
11.8.1 Cordlife Company Information
11.8.2 Cordlife Non-Invasive Prenatal Screening (NIPS) Product Offered
11.8.3 Cordlife Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Cordlife Main Business Overview
11.8.5 Cordlife Latest Developments
11.9 BGI Genomics
11.9.1 BGI Genomics Company Information
11.9.2 BGI Genomics Non-Invasive Prenatal Screening (NIPS) Product Offered
11.9.3 BGI Genomics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 BGI Genomics Main Business Overview
11.9.5 BGI Genomics Latest Developments
11.10 Berry Genomics
11.10.1 Berry Genomics Company Information
11.10.2 Berry Genomics Non-Invasive Prenatal Screening (NIPS) Product Offered
11.10.3 Berry Genomics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Berry Genomics Main Business Overview
11.10.5 Berry Genomics Latest Developments
11.11 Annaroad
11.11.1 Annaroad Company Information
11.11.2 Annaroad Non-Invasive Prenatal Screening (NIPS) Product Offered
11.11.3 Annaroad Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Annaroad Main Business Overview
11.11.5 Annaroad Latest Developments
11.12 Genesky
11.12.1 Genesky Company Information
11.12.2 Genesky Non-Invasive Prenatal Screening (NIPS) Product Offered
11.12.3 Genesky Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Genesky Main Business Overview
11.12.5 Genesky Latest Developments
11.13 Weihansi Biomedical Technology
11.13.1 Weihansi Biomedical Technology Company Information
11.13.2 Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Product Offered
11.13.3 Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Weihansi Biomedical Technology Main Business Overview
11.13.5 Weihansi Biomedical Technology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size (2021-2032)
2.1.2 Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Non-Invasive Prenatal Screening (NIPS) by Country/Region (2021, 2025 & 2032)
2.2 Non-Invasive Prenatal Screening (NIPS) Segment by Type
2.2.1 Screening in Uncomplicated Pregnancies
2.2.2 Screening in High-Risk Pregnancies
2.2.3 Others
2.2.4 Non-Invasive Prenatal Screening (NIPS) Market Size by Type
2.2.4.1 Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2021-2026)
2.3 Non-Invasive Prenatal Screening (NIPS) Segment by Screening Timing
2.3.1 First-trimester Screening
2.3.2 Second-trimester Screening
2.3.3 Late-pregnancy Screening
2.3.4 Non-Invasive Prenatal Screening (NIPS) Market Size by Screening Timing
2.3.4.1 Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Screening Timing (2021 VS 2025 VS 2032)
2.3.4.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Screening Timing (2021-2026)
2.4 Non-Invasive Prenatal Screening (NIPS) Segment by Service Model
2.4.1 Public Health Program
2.4.2 Consumer
2.4.3 Others
2.4.4 Non-Invasive Prenatal Screening (NIPS) Market Size by Service Model
2.4.4.1 Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Service Model (2021 VS 2025 VS 2032)
2.4.4.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Service Model (2021-2026)
2.5 Non-Invasive Prenatal Screening (NIPS) Segment by Application
2.5.1 Public Hospitals
2.5.2 Private Hospitals
2.5.3 Non-Invasive Prenatal Screening (NIPS) Market Size by Application
2.5.3.1 Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.3.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2021-2026)
3 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET SIZE BY PLAYER
3.1 Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Player
3.1.1 Global Non-Invasive Prenatal Screening (NIPS) Revenue by Player (2021-2026)
3.1.2 Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Player (2021-2026)
3.2 Global Non-Invasive Prenatal Screening (NIPS) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-INVASIVE PRENATAL SCREENING (NIPS) BY REGION
4.1 Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2021-2026)
4.2 Global Non-Invasive Prenatal Screening (NIPS) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-Invasive Prenatal Screening (NIPS) Market Size Growth (2021-2026)
4.4 APAC Non-Invasive Prenatal Screening (NIPS) Market Size Growth (2021-2026)
4.5 Europe Non-Invasive Prenatal Screening (NIPS) Market Size Growth (2021-2026)
4.6 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026)
5.2 Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026)
5.3 Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2021-2026)
6.2 APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026)
6.3 APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026)
7.2 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026)
7.3 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) by Region (2021-2026)
8.2 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026)
8.3 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET FORECAST
10.1 Global Non-Invasive Prenatal Screening (NIPS) Forecast by Region (2027-2032)
10.1.1 Global Non-Invasive Prenatal Screening (NIPS) Forecast by Region (2027-2032)
10.1.2 Americas Non-Invasive Prenatal Screening (NIPS) Forecast
10.1.3 APAC Non-Invasive Prenatal Screening (NIPS) Forecast
10.1.4 Europe Non-Invasive Prenatal Screening (NIPS) Forecast
10.1.5 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Forecast
10.2 Americas Non-Invasive Prenatal Screening (NIPS) Forecast by Country (2027-2032)
10.2.1 United States Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.2.2 Canada Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.2.3 Mexico Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.2.4 Brazil Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.3 APAC Non-Invasive Prenatal Screening (NIPS) Forecast by Region (2027-2032)
10.3.1 China Non-Invasive Prenatal Screening (NIPS) Market Forecast
10.3.2 Japan Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.3.3 Korea Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.3.4 Southeast Asia Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.3.5 India Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.3.6 Australia Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.4 Europe Non-Invasive Prenatal Screening (NIPS) Forecast by Country (2027-2032)
10.4.1 Germany Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.4.2 France Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.4.3 UK Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.4.4 Italy Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.4.5 Russia Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.5 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Forecast by Region (2027-2032)
10.5.1 Egypt Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.5.2 South Africa Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.5.3 Israel Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.5.4 Turkey Market Non-Invasive Prenatal Screening (NIPS) Forecast
10.6 Global Non-Invasive Prenatal Screening (NIPS) Forecast by Type (2027-2032)
10.7 Global Non-Invasive Prenatal Screening (NIPS) Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Non-Invasive Prenatal Screening (NIPS) Forecast
11 KEY PLAYERS ANALYSIS
11.1 Revvity
11.1.1 Revvity Company Information
11.1.2 Revvity Non-Invasive Prenatal Screening (NIPS) Product Offered
11.1.3 Revvity Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Revvity Main Business Overview
11.1.5 Revvity Latest Developments
11.2 Quest Diagnostics
11.2.1 Quest Diagnostics Company Information
11.2.2 Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Product Offered
11.2.3 Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Quest Diagnostics Main Business Overview
11.2.5 Quest Diagnostics Latest Developments
11.3 MedGenome
11.3.1 MedGenome Company Information
11.3.2 MedGenome Non-Invasive Prenatal Screening (NIPS) Product Offered
11.3.3 MedGenome Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 MedGenome Main Business Overview
11.3.5 MedGenome Latest Developments
11.4 Mayo Clinic Laboratories
11.4.1 Mayo Clinic Laboratories Company Information
11.4.2 Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Product Offered
11.4.3 Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Mayo Clinic Laboratories Main Business Overview
11.4.5 Mayo Clinic Laboratories Latest Developments
11.5 SYNLAB
11.5.1 SYNLAB Company Information
11.5.2 SYNLAB Non-Invasive Prenatal Screening (NIPS) Product Offered
11.5.3 SYNLAB Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 SYNLAB Main Business Overview
11.5.5 SYNLAB Latest Developments
11.6 Veritas Genetics
11.6.1 Veritas Genetics Company Information
11.6.2 Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Product Offered
11.6.3 Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Veritas Genetics Main Business Overview
11.6.5 Veritas Genetics Latest Developments
11.7 GGA
11.7.1 GGA Company Information
11.7.2 GGA Non-Invasive Prenatal Screening (NIPS) Product Offered
11.7.3 GGA Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 GGA Main Business Overview
11.7.5 GGA Latest Developments
11.8 Cordlife
11.8.1 Cordlife Company Information
11.8.2 Cordlife Non-Invasive Prenatal Screening (NIPS) Product Offered
11.8.3 Cordlife Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Cordlife Main Business Overview
11.8.5 Cordlife Latest Developments
11.9 BGI Genomics
11.9.1 BGI Genomics Company Information
11.9.2 BGI Genomics Non-Invasive Prenatal Screening (NIPS) Product Offered
11.9.3 BGI Genomics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 BGI Genomics Main Business Overview
11.9.5 BGI Genomics Latest Developments
11.10 Berry Genomics
11.10.1 Berry Genomics Company Information
11.10.2 Berry Genomics Non-Invasive Prenatal Screening (NIPS) Product Offered
11.10.3 Berry Genomics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Berry Genomics Main Business Overview
11.10.5 Berry Genomics Latest Developments
11.11 Annaroad
11.11.1 Annaroad Company Information
11.11.2 Annaroad Non-Invasive Prenatal Screening (NIPS) Product Offered
11.11.3 Annaroad Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Annaroad Main Business Overview
11.11.5 Annaroad Latest Developments
11.12 Genesky
11.12.1 Genesky Company Information
11.12.2 Genesky Non-Invasive Prenatal Screening (NIPS) Product Offered
11.12.3 Genesky Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Genesky Main Business Overview
11.12.5 Genesky Latest Developments
11.13 Weihansi Biomedical Technology
11.13.1 Weihansi Biomedical Technology Company Information
11.13.2 Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Product Offered
11.13.3 Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Weihansi Biomedical Technology Main Business Overview
11.13.5 Weihansi Biomedical Technology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Non-Invasive Prenatal Screening (NIPS) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Screening in Uncomplicated Pregnancies
Table 4. Major Players of Screening in High-Risk Pregnancies
Table 5. Major Players of Others
Table 6. Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2021-2026)
Table 9. Major Players of First-trimester Screening
Table 10. Major Players of Second-trimester Screening
Table 11. Major Players of Late-pregnancy Screening
Table 12. Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Screening Timing (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Screening Timing (2021-2026) & ($ millions)
Table 14. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Screening Timing (2021-2026)
Table 15. Major Players of Public Health Program
Table 16. Major Players of Consumer
Table 17. Major Players of Others
Table 18. Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Service Model (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Service Model (2021-2026) & ($ millions)
Table 20. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Service Model (2021-2026)
Table 21. Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026) & ($ millions)
Table 23. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2021-2026)
Table 24. Global Non-Invasive Prenatal Screening (NIPS) Revenue by Player (2021-2026) & ($ millions)
Table 25. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Player (2021-2026)
Table 26. Non-Invasive Prenatal Screening (NIPS) Key Players Head office and Products Offered
Table 27. Non-Invasive Prenatal Screening (NIPS) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2021-2026) & ($ millions)
Table 31. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2021-2026)
Table 32. Global Non-Invasive Prenatal Screening (NIPS) Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country (2021-2026)
Table 36. Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2021-2026)
Table 38. Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2021-2026)
Table 40. APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2021-2026)
Table 42. APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country (2021-2026)
Table 46. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of Non-Invasive Prenatal Screening (NIPS)
Table 52. Key Market Challenges & Risks of Non-Invasive Prenatal Screening (NIPS)
Table 53. Key Industry Trends of Non-Invasive Prenatal Screening (NIPS)
Table 54. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. Revvity Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 59. Revvity Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 60. Revvity Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Revvity Main Business
Table 62. Revvity Latest Developments
Table 63. Quest Diagnostics Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 64. Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 65. Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Quest Diagnostics Main Business
Table 67. Quest Diagnostics Latest Developments
Table 68. MedGenome Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 69. MedGenome Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 70. MedGenome Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. MedGenome Main Business
Table 72. MedGenome Latest Developments
Table 73. Mayo Clinic Laboratories Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 74. Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 75. Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Mayo Clinic Laboratories Main Business
Table 77. Mayo Clinic Laboratories Latest Developments
Table 78. SYNLAB Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 79. SYNLAB Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 80. SYNLAB Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. SYNLAB Main Business
Table 82. SYNLAB Latest Developments
Table 83. Veritas Genetics Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 84. Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 85. Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Veritas Genetics Main Business
Table 87. Veritas Genetics Latest Developments
Table 88. GGA Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 89. GGA Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 90. GGA Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. GGA Main Business
Table 92. GGA Latest Developments
Table 93. Cordlife Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 94. Cordlife Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 95. Cordlife Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Cordlife Main Business
Table 97. Cordlife Latest Developments
Table 98. BGI Genomics Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 99. BGI Genomics Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 100. BGI Genomics Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. BGI Genomics Main Business
Table 102. BGI Genomics Latest Developments
Table 103. Berry Genomics Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 104. Berry Genomics Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 105. Berry Genomics Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Berry Genomics Main Business
Table 107. Berry Genomics Latest Developments
Table 108. Annaroad Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 109. Annaroad Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 110. Annaroad Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Annaroad Main Business
Table 112. Annaroad Latest Developments
Table 113. Genesky Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 114. Genesky Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 115. Genesky Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Genesky Main Business
Table 117. Genesky Latest Developments
Table 118. Weihansi Biomedical Technology Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 119. Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 120. Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Weihansi Biomedical Technology Main Business
Table 122. Weihansi Biomedical Technology Latest Developments
Table 1. Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Non-Invasive Prenatal Screening (NIPS) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Screening in Uncomplicated Pregnancies
Table 4. Major Players of Screening in High-Risk Pregnancies
Table 5. Major Players of Others
Table 6. Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2021-2026)
Table 9. Major Players of First-trimester Screening
Table 10. Major Players of Second-trimester Screening
Table 11. Major Players of Late-pregnancy Screening
Table 12. Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Screening Timing (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Screening Timing (2021-2026) & ($ millions)
Table 14. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Screening Timing (2021-2026)
Table 15. Major Players of Public Health Program
Table 16. Major Players of Consumer
Table 17. Major Players of Others
Table 18. Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Service Model (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Service Model (2021-2026) & ($ millions)
Table 20. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Service Model (2021-2026)
Table 21. Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026) & ($ millions)
Table 23. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2021-2026)
Table 24. Global Non-Invasive Prenatal Screening (NIPS) Revenue by Player (2021-2026) & ($ millions)
Table 25. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Player (2021-2026)
Table 26. Non-Invasive Prenatal Screening (NIPS) Key Players Head office and Products Offered
Table 27. Non-Invasive Prenatal Screening (NIPS) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2021-2026) & ($ millions)
Table 31. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2021-2026)
Table 32. Global Non-Invasive Prenatal Screening (NIPS) Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country (2021-2026)
Table 36. Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2021-2026)
Table 38. Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2021-2026)
Table 40. APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2021-2026)
Table 42. APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country (2021-2026)
Table 46. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of Non-Invasive Prenatal Screening (NIPS)
Table 52. Key Market Challenges & Risks of Non-Invasive Prenatal Screening (NIPS)
Table 53. Key Industry Trends of Non-Invasive Prenatal Screening (NIPS)
Table 54. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. Revvity Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 59. Revvity Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 60. Revvity Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Revvity Main Business
Table 62. Revvity Latest Developments
Table 63. Quest Diagnostics Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 64. Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 65. Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Quest Diagnostics Main Business
Table 67. Quest Diagnostics Latest Developments
Table 68. MedGenome Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 69. MedGenome Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 70. MedGenome Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. MedGenome Main Business
Table 72. MedGenome Latest Developments
Table 73. Mayo Clinic Laboratories Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 74. Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 75. Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Mayo Clinic Laboratories Main Business
Table 77. Mayo Clinic Laboratories Latest Developments
Table 78. SYNLAB Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 79. SYNLAB Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 80. SYNLAB Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. SYNLAB Main Business
Table 82. SYNLAB Latest Developments
Table 83. Veritas Genetics Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 84. Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 85. Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Veritas Genetics Main Business
Table 87. Veritas Genetics Latest Developments
Table 88. GGA Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 89. GGA Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 90. GGA Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. GGA Main Business
Table 92. GGA Latest Developments
Table 93. Cordlife Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 94. Cordlife Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 95. Cordlife Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Cordlife Main Business
Table 97. Cordlife Latest Developments
Table 98. BGI Genomics Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 99. BGI Genomics Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 100. BGI Genomics Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. BGI Genomics Main Business
Table 102. BGI Genomics Latest Developments
Table 103. Berry Genomics Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 104. Berry Genomics Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 105. Berry Genomics Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Berry Genomics Main Business
Table 107. Berry Genomics Latest Developments
Table 108. Annaroad Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 109. Annaroad Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 110. Annaroad Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Annaroad Main Business
Table 112. Annaroad Latest Developments
Table 113. Genesky Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 114. Genesky Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 115. Genesky Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Genesky Main Business
Table 117. Genesky Latest Developments
Table 118. Weihansi Biomedical Technology Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
Table 119. Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Product Offered
Table 120. Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Weihansi Biomedical Technology Main Business
Table 122. Weihansi Biomedical Technology Latest Developments
LIST OF FIGURES
Figure 1. Non-Invasive Prenatal Screening (NIPS) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Non-Invasive Prenatal Screening (NIPS) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Non-Invasive Prenatal Screening (NIPS) Sales Market Share by Country/Region (2025)
Figure 8. Non-Invasive Prenatal Screening (NIPS) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type in 2025
Figure 10. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Screening Timing in 2025
Figure 11. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Service Model in 2025
Figure 12. Non-Invasive Prenatal Screening (NIPS) in Public Hospitals
Figure 13. Global Non-Invasive Prenatal Screening (NIPS) Market: Public Hospitals (2021-2026) & ($ millions)
Figure 14. Non-Invasive Prenatal Screening (NIPS) in Private Hospitals
Figure 15. Global Non-Invasive Prenatal Screening (NIPS) Market: Private Hospitals (2021-2026) & ($ millions)
Figure 16. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application in 2025
Figure 17. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Player in 2025
Figure 18. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2021-2026)
Figure 19. Americas Non-Invasive Prenatal Screening (NIPS) Market Size 2021-2026 ($ millions)
Figure 20. APAC Non-Invasive Prenatal Screening (NIPS) Market Size 2021-2026 ($ millions)
Figure 21. Europe Non-Invasive Prenatal Screening (NIPS) Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size 2021-2026 ($ millions)
Figure 23. Americas Non-Invasive Prenatal Screening (NIPS) Value Market Share by Country in 2025
Figure 24. United States Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region in 2025
Figure 29. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2021-2026)
Figure 30. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2021-2026)
Figure 31. China Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 35. India Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country in 2025
Figure 38. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2021-2026)
Figure 39. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2021-2026)
Figure 40. Germany Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 41. France Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 54. APAC Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 55. Europe Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 57. United States Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 58. Canada Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 59. Mexico Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 60. Brazil Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 61. China Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 62. Japan Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 63. Korea Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 65. India Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 66. Australia Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 67. Germany Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 68. France Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 69. UK Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 70. Italy Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 71. Russia Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 72. Egypt Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 73. South Africa Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 74. Israel Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 75. Turkey Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 76. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 1. Non-Invasive Prenatal Screening (NIPS) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Non-Invasive Prenatal Screening (NIPS) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Non-Invasive Prenatal Screening (NIPS) Sales Market Share by Country/Region (2025)
Figure 8. Non-Invasive Prenatal Screening (NIPS) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type in 2025
Figure 10. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Screening Timing in 2025
Figure 11. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Service Model in 2025
Figure 12. Non-Invasive Prenatal Screening (NIPS) in Public Hospitals
Figure 13. Global Non-Invasive Prenatal Screening (NIPS) Market: Public Hospitals (2021-2026) & ($ millions)
Figure 14. Non-Invasive Prenatal Screening (NIPS) in Private Hospitals
Figure 15. Global Non-Invasive Prenatal Screening (NIPS) Market: Private Hospitals (2021-2026) & ($ millions)
Figure 16. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application in 2025
Figure 17. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Player in 2025
Figure 18. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2021-2026)
Figure 19. Americas Non-Invasive Prenatal Screening (NIPS) Market Size 2021-2026 ($ millions)
Figure 20. APAC Non-Invasive Prenatal Screening (NIPS) Market Size 2021-2026 ($ millions)
Figure 21. Europe Non-Invasive Prenatal Screening (NIPS) Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size 2021-2026 ($ millions)
Figure 23. Americas Non-Invasive Prenatal Screening (NIPS) Value Market Share by Country in 2025
Figure 24. United States Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region in 2025
Figure 29. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2021-2026)
Figure 30. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2021-2026)
Figure 31. China Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 35. India Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country in 2025
Figure 38. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2021-2026)
Figure 39. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2021-2026)
Figure 40. Germany Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 41. France Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 54. APAC Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 55. Europe Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 57. United States Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 58. Canada Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 59. Mexico Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 60. Brazil Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 61. China Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 62. Japan Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 63. Korea Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 65. India Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 66. Australia Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 67. Germany Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 68. France Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 69. UK Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 70. Italy Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 71. Russia Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 72. Egypt Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 73. South Africa Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 74. Israel Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 75. Turkey Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
Figure 76. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Non-Invasive Prenatal Screening (NIPS) Market Size 2027-2032 ($ millions)
